| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Effective Pharmacotherapy |
2023―Dec―19 |
Abnormal Uterine Bleeding in Adolescents and COVID-19: Etiology and Pathogenesis |
A.Yu. Kurmangaleeva, Ye.V. Sibirskaya, S.A. Korotkova, G.T. Osipova |
| 2 |
[GO] |
Effective Pharmacotherapy |
2023―Jul―18 |
Menstrual Irregularities in Adolescents Caused by the COVID-19 Pandemic. Literature Review |
L.V. Adamyan, Ye.V. Sibirskaya, I.V. Karachentsova, Yu.A. Kirillova, M.A. Loshkareva, A.V. Krasivskaya |
| 3 |
[GO] |
Effective Pharmacotherapy |
2023―Mar―31 |
Diagnostic Markers of Heart Damage in Patients with a Moderate Form of New Coronavirus Infection |
A.V. Ageykin, D.V. Usenko, A.V. Gorelov, V.L. Melnikov, K.A. Zvonova |
| 4 |
[GO] |
Effective Pharmacotherapy |
2022―Jul―01 |
Gastrointestinal Tract in Captivity at COVID-19: the Impact of a New Coronavirus Infection on the Course and Outcome of Diverticular Colon Disease |
V.I. Mordasova, D.V. Kopylova, I.S. Podstavkina, E.N. Ponomareva, I.V. Timchenko |
| 5 |
[GO] |
Effective Pharmacotherapy |
2022―Mar―31 |
Issues of Vaccination of SARS-CoV-2 Infection in Chronic Liver Diseases |
E.V. Vinnitskaya, A.N. Ivanov, Yu.G. Sandler |
| 6 |
[GO] |
Effective Pharmacotherapy |
2022―Mar―29 |
Secondary Prevention of Ischemic Stroke in a Pandemic of the New Coronavirus Infection COVID-19: Paradigms and Collisions |
M.V. Putilina |
| 7 |
[GO] |
Effective Pharmacotherapy |
2021―Dec―30 |
Features of Providing Medical Care to Patients with IBD in the Context of a Pandemic of the New Coronavirus Infection COVID-19 in the Voronezh Region |
V.I. Mordasova, D.V. Kopylova, I.S. Podstavkina, Е.V. Sokoltsov |
| 8 |
[GO] |
Effective Pharmacotherapy |
2021―Dec―29 |
Prospects for the Use of Combined Lysozyme Drugs in COVID-19 |
A.V. Gorelov, D.V. Usenko, L.P. Antonova, L.I. Kozlovskaya, Ye.Yu. Shustova, V.P. Volok |
| 9 |
[GO] |
Effective Pharmacotherapy |
2021―Jan―18 |
Relevance of the Use of Mucoactive Drugs for Coughing with Different Etiopathogenesis During the COVID-19 Pandemic |
M.A. Ryabova |
| 10 |
[GO] |
Effective Pharmacotherapy |
2020―Dec―11 |
Gastroenterological Manifestations in Patients with COVID-19 Infection |
M.I. Shengeliya, V.A. Ivanova, V.I. Vechorko, O.V. Averkov, O.A. Shapsigova, D.S. Bordin |
| 11 |
[GO] |
Effective Pharmacotherapy |
2020―Nov―09 |
COVID-19 Pandemic As the Trigger for Correction of the Approaches to Management Type 2 Diabetes |
K.V. Ovsyannikov |
| 12 |
[GO] |
Effective Pharmacotherapy |
2020―Nov―09 |
To the Issue of Intoxication and Diarrhea Syndrome Treatment in the Case of Coronavirus Infection |
A.I. Pavlov, A.V. Khovanov, V.E. Bakirova, Zh.V. Fadina, A.K. Khavanshanov, N.M. Olshanskaya |
| 13 |
[GO] |
Effective Pharmacotherapy |
2020―May―29 |
Clinical Aspects of Liver Damage in COVID-19 |
Yu.G. Sandler, Ye.V. Vinnitskaya, T.Yu. Khaymenova, D.S. Bordin |
| 14 |
[GO] |
Effective Pharmacotherapy |
2020―May―29 |
COVID-19 and Gastrointestinal Tract |
D.S. Bordin, M.A. Kiriukova, M.I. Shengelia, S.V. Kolbasnikov |
